参考文献/References:
[1] YU K H,CHEN D Y,CHEN J H,et al.Management of gout and hyperuricemia:multidisciplinary consensus in Taiwan[J].Int J Rheum Dis,2018,21(4):772-787.
[2] WOLYNCEWICZ B,MAJOR T J,DELAHUNT B,et al.The epigenome:key to understanding and predicting gout flares[J].Pathology,2021,53(7):824-829.
[3] 王婕,张晓东.老年痛风性关节炎发病危险因素及其中医证候分布特点分析[J].辽宁中医杂志,2024,51(12):82-85.
[4] NEOGI T,TH A JANSEN T L,DALBETH N,et al.2015 Gout Classification Criteria:an American College of Rheumatology/European League Against Rheumatism collaborative initiative[J].Arthritis Rheumatol,2015,67(10):2557-2568.
[5] 国家中医药管理局.中医病证诊断疗效标准[M].南京:南京大学出版社,2012.
[6] 国家食品药品监督管理局.中药新药临床研究指导原则(试行)[S].北京:中国医药科技出版社,2002.
[7] 姚霞飞,林世德.急、慢性痛风性关节炎的肌骨超声表现对比研究[J].影像研究与医学应用,2024,8(2):50-52.
[8] 中国医师协会超声医师分会.中国肌骨超声检查指南[M].北京:人民卫生出版社,2017.
[9] 蹇丽娟,吴淑琼.痛风性关节炎中医研究进展[J].中医药信息,2022,39(7):81-85.
[10] GUTIERREZ M,SCHMIDT W A,THIELE R G,et al.International consensus for ultrasound lesions in gout:results of Delphi process and web-reliability exercise[J].Rheumatology(Oxford),2015,54(10):1797-1805.
[11] 李春歌,王博冉,乔春梅,等.多模态超声在痛风性关节炎中的诊断价值[J].内蒙古医科大学学报,2021,43(3):324-327.
[12] PARTHASARATHY P,VIVEKANANDAN S.Urate crystal deposition,prevention and various diagnosis techniques of GOUT arthritis disease:a comprehensive review[J].Health Inf Sci Syst,2018,6(1):19.
[13] 杜明瑞,赵哲,李秦,等.加味四妙散对湿热痹阻型慢性痛风性关节炎炎症因子的影响及相关性分析[J].中医药信息,2024,41(5):56-63.
[14] WU M,LIU F J,CHEN J,et al.Prevalence and factors associated with bone erosion in patients with gout[J].Arthritis Care Res,2019,71(12):1653-1659.
[15] 杨小敏.痛风性关节炎患者中医证型与免疫学指标的相关性研究[J].基层医学论坛,2024,28(22):152-156.
[16] 肖燕燕,李建宁,陈慧君,等.痛风性关节炎中医证型与肌骨超声表现的相关性研究[J].山东中医杂志,2021,40(4):356-361.
(收稿日期:2025-03-16)